Intravenous Thrombolytic Therapy in Acute Stroke: Problems and Solutions
Journal Title: UNKNOWN - Year 2017, Vol 23, Issue 4
Abstract
Use of intravenous tissue plasminogen activator (tPA) is one of the key elements of acute ischemic stroke management. Its use has not become widespread, and has faced significant problems in our country for more than a quarter of a century most probably due to many unanswered questions about issues related with daily practice. However, recent developments, which adequately focused and found solutions for most of these problems and questions, have led to a major change of point of view and understanding of the hyperacute management of stroke. This article, in the light of the relevant literature, discusses and provides clear recommendations for questions directed by neurologists practicing in Turkey mainly about typical neurologic issues faced in the setting of tPA use for acute stroke.
Authors and Affiliations
Mehmet Akif Topçuoğlu, Ethem Murat Arsava, Atilla Özcan Özdemir, Erdem Gürkaş, Dilek Necioğlu Örken, Şerefnur Öztürk
Keywords
Related Articles
- EP ID EP276785
- DOI 10.4274/tnd.71084
- Views 89
- Downloads 0
Intravenous Thrombolytic Therapy in Acute Stroke: Frequent Systemic Problems and Solutions
One of the most important reasons why the use of the intravenous (IV) tissue plasminogen activator (tPA), which is one of the key elements of acute ischemic stroke treatment, is not sufficiently widespread is the fact th...
A Case of Acute Bilateral Ptosis: SURF-1 Mutation
.
Chronic Progressive Neuro-Behçet’s Disease: Magnetic Resonance Spectroscopy and Apparent Diffusion Coefficient Findings
.
Diffusion Tensor Imaging in a Patient with Joubert Syndrome
.
Aortic Dissection Presenting with Transient Paraplegia
.